Showing the single result
Ranolazine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Polymeric Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute stability of the modified-release polymers.
Active Ingredient Strength Primary Clinical Function Ranolazine INN/Ph.Eur. 500 mg (Extended-Release) Global Clinical Standard: Base initiation dose for chronic angina management (taken twice daily). Ranolazine INN/Ph.Eur. 1000 mg (Extended-Release) Advanced maintenance dose for severe, refractory angina requiring maximum cellular relaxation. Excipients Hypromellose (HPMC) / Methacrylic Acid Copolymer / Microcrystalline Cellulose / Magnesium Stearate Hydrophilic Polymer Matrix / Enteric Matrix / Diluent (Engineered to form a viscous gel layer that controls the strict 12-hour drug diffusion rate) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 60 (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
